Lanzamiento Enero 2027

Ensayo controlado aleatorizado2007

Decreasing linoleic acid with constant alpha-linolenic acid in dietary fats increases (n-3) eicosapentaenoic acid in plasma phospholipids in healthy men

Liou YA, King DJ, Zibrik D, Innis SM

The Journal of nutrition · 150 citas

Cómo se estudió

Diseño
Ensayo controlado aleatorizado (indexado por PubMed)
Estudiado en
Personas
Resultado principal
Marcadores de salud y funcionamiento
Consumo medido con
No se indica

Quién lo pagó

Financiación
Financiación independiente
Organización sin fines de lucro
Molly Towell Perinatal Research Foundation
Organización sin fines de lucro
Canadian Foundation for Dietetic Research
Gobierno
Michael Smith Health Research BC

Según 3 financiadores declarados.

Publicación

Publicado
2007-04-01 · J Nutr · vol. 137 · número 4 · págs. 945–952
Editorial
Elsevier BV
Citado
231 citas · más que el 99% de estudios similares · 16.7× el promedio de su campo
Impacto
Entre el 10 % más citado de su campo
Referencias
55 trabajos
Acceso
Lectura gratuita
Áreas de investigación
Fatty Acid Research and Health · Aquaculture Nutrition and Growth · Lipid metabolism and biosynthesis
Palabras clave
linoleic acid, alpha-linolenic acid, eicosapentaenoic acid, docosahexaenoic acid, arachidonic acid, plasma phospholipid fatty acids, dietary fat composition, vegetable oil replacement, omega-3 fatty acid metabolism, n-6/n-3 ratio, platelet aggregation, inflammatory markers, healthy men
MeSH
humans, inflammation, lipids, dietary fats, alpha-linolenic acid, eicosapentaenoic acid, fatty acids, arachidonic acid, linoleic acid, phospholipids, diet, cross-over studies, platelet aggregation, dose-response relationship, drug, adult, male, biomarkers

4 autores

  • Yi-Fan Liou🇨🇦University of British Columbia; Child and Family Research Institute
  • D. Janette King🇨🇦University of British Columbia; Child and Family Research Institute
  • Deborah Zibrik🇨🇦University of British Columbia; Child and Family Research Institute
  • Sheila Margaret Innis🇨🇦 · autor de correspondenciaUniversity of British Columbia; Child and Family Research Institute

Resumen

El texto original del estudio, en el idioma en que se publicó.

High linoleic acid (LA) intakes have been suggested to reduce alpha-linolenic acid [ALA, 18:3(n-3)] metabolism to eicosapentaenoic acid [EPA, 20:5(n-3)] and docosahexaenoic acid [DHA, 22:6(n-3)], and favor high arachidonic acid [ARA, 20:4(n-6)]. We used a randomized cross-over study with men (n = 22) to compare the effect of replacing vegetable oils high in LA with oils low in LA in foods, while maintaining constant ALA, for 4 wk each, on plasma (n-3) fatty acids. Nonvegetable sources of fat, except fish and seafoods, were unrestricted. We determined plasma phospholipid fatty acids at wk 0, 2, 4, 6, and 8, and triglycerides, cholesterol, serum CRP, and IL-6, and platelet aggregation at wk 0, 4, and 8. LA and ALA intakes were 3.8 +/- 0.12% and 1.0 +/- 0.05%, and 10.5 +/- 0.53% and 1.1 +/- 0.06% energy with LA:ALA ratios of 4:0 and 10:1 during the low and high LA diets, respectively. The plasma phospholipid LA was higher and EPA was lower during the high than during the low LA diet period (P < 0.001), but DHA declined over the 8-wk period (r = -0.425, P < 0.001). The plasma phospholipid ARA:EPA ratios were (mean +/- SEM) 20.7 +/- 1.52 and 12.9 +/- 1.01 after 4 wk consuming the high or low LA diets, respectively (P < 0.001); LA was inversely associated with EPA (r = -0.729, P < 0.001) but positively associated with ARA:EPA (r = 0.432, P < 0.001). LA intake did not influence ALA, ARA, DPA, DHA, or total, LDL or HDL cholesterol, CRP or IL-6, or platelet aggregation. In conclusion, high LA intakes decrease plasma phospholipid EPA and increase the ARA:EPA ratio, but do not favor higher ARA.

Resumen vía Europe PMC. Los derechos de autor siguen siendo de los autores o la editorial.

Confianza de la comunidad

Cargando…

¿Cuánto confías en los hallazgos de este estudio?

0 · nada10 · totalmente

Comentarios

¿Algo está mal aquí?

Señala este estudio si su información, etiquetas o financiación parecen incorrectas. Un editor revisa cada señalamiento.

Información educativa sobre investigación publicada. No es consejo médico ni una recomendación para empezar o dejar nada.